Trees Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

Trees Investment Counsel’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.03M	Hold	35,955	–	–	1.79%	30
2015 Q2	$2.13M	Buy	35,955 +472	+1%	+$29.1K	1.69%	33
2015 Q1	$2.21M	Sell	35,483 -1,000	-3%	-$58.1K	1.79%	30
2014 Q4	$2.1M	Hold	36,483	–	–	1.69%	32
2014 Q3	$1.96M	Hold	36,483	–	–	1.58%	34
2014 Q2	$1.91M	Sell	36,483 -1,122	-3%	-$57.3K	1.5%	36
2014 Q1	$1.99M	Sell	37,605 -700	-2%	-$32.4K	1.59%	33
2013 Q4	$1.53M	Hold	38,305	–	–	1.22%	39
2013 Q3	$1.45M	Sell	38,305 -400	-1%	-$15.6K	1.26%	37
2013 Q2	$1.52M	Buy	+38,705	New	+$1.51M	1.39%	37

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Trees Investment Counsel's TEVA Position: Q3 2015 in Review

Trees Investment Counsel held its Teva Pharmaceuticals (TEVA) position steady in Q3 2015 at 35,955 shares worth $2.03M. The position accounts for 1.79% of the portfolio, ranked #30.

Trees Investment Counsel first reported a position in TEVA in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.21M in Q1 2015. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

Trees Investment Counsel held 35,955 shares of Teva Pharmaceuticals worth $2.03M as of Q3 2015.
Trees Investment Counsel left its Teva Pharmaceuticals share count unchanged in Q3 2015.
Teva Pharmaceuticals made up 1.79% of Trees Investment Counsel's portfolio in Q3 2015, its #30 holding.
Trees Investment Counsel first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
Trees Investment Counsel's Teva Pharmaceuticals position peaked at $2.21M in Q1 2015.
823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Trees Investment Counsel's 13F filing for Q3 2015, filed 16 Oct 2015.